Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors

Table 4 Linear regression model of predictors of flow-mediated dilatation of the brachial artery

Parameter	ß	Tolerance	p
Age at first MACE (years)	0.689	4.394	p = 0.022
Systolic blood pressure (mm Hg)	-0.401	-3.008	p = 0.057
Lipoprotein (a) (mg/l)	-0.248	-2.074	p = 0.130
hs-CRP (mg/l)	-1.200	-5.994	p = 0.009
VCAM1 (mg/l)	-0.992	-7.169	p = 0.006
OCP (Abs-sum)	1.428	5.196	p = 0.014
OHP (Abs-sum)	-1.473	-6.248	p = 0.008

R² (part of variability explained with the model) = 0.988, p = 0.020, MACE major adverse cardiac events, hs-CRP high-sensitivity C-reactive protein, VCAM1 vascular cell adhesion protein 1, OCP overall coagulation potential, OHP overall hemostasis potential

ISSN: 1476-7120